Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Agenus and BMS Announce License for Anti-TIGIT Bispecific Antibody Program

americanpharmaceuticalreviewMay 19, 2021

Tag: Agenus , BMS , AGEN1777 , TIGIT

PharmaSources Customer Service